Find uplifting stories about heroes, innovations, and solutions
23 results for "hiv treatment"
A radical experiment in rural Haiti proved HIV treatment could work anywhere, leading to PEPFAR—a program that has now saved 26 million lives. Partners In Health has spent decades building and defending this lifesaving legacy.
A 63-year-old man became the first person to achieve HIV remission through a bone marrow transplant from his sibling, opening new possibilities for HIV treatment. His brother carried a rare genetic mutation that makes cells resistant to the virus.
New weight loss medications like Ozempic could help address obesity in people living with HIV, particularly black women who are disproportionately affected. Early research in South Africa is exploring how these breakthrough drugs might improve health outcomes for this community.
Nigeria just introduced a twice-yearly HIV injection that could replace daily pills and help eliminate AIDS within six years. The breakthrough treatment, called Lenacapavir, offers new hope for millions while reducing stigma and improving care access.
Breakthrough weight loss medications like Ozempic could help tackle rising obesity rates among people living with HIV in South Africa. Early research from rural KwaZulu-Natal shows these drugs work just as well for HIV patients as everyone else.
Breakthrough weight loss medications like Ozempic could help address rising obesity rates among people living with HIV in South Africa. Early research suggests these drugs work just as well for HIV patients as everyone else.
When U.S. aid cuts disrupted HIV treatment in Nigeria, dozens of volunteers walked dusty village paths to keep patients alive. Their door-to-door missions brought over 1,000 people back into care.
Researchers at Case Western Reserve University are using cancer treatment techniques to wake up the immune system and hunt down HIV hiding in the body. The breakthrough could one day help people living with HIV reduce or stop lifelong medication.
As international donor support declines, Nigerian health advocates are winning critical commitments from state lawmakers to fund HIV and TB programs locally. The move could protect decades of progress in treating diseases that affect millions across Africa.
As international donors pull back, Nigerian lawmakers are pledging to increase domestic funding for HIV and tuberculosis programs that have saved thousands of lives. The move could protect decades of hard-won progress in treating these diseases.
When U.S. aid cuts ended his $50 monthly salary, Harerimana Ismail kept showing up to help HIV-positive children in Uganda. His dedication, and that of others like him, helped prevent a predicted collapse in global HIV treatment.
A simpler two-drug HIV treatment performed just as well as the current gold standard in clinical trials, with FDA approval expected this April. The breakthrough could offer people living with HIV a new option with fewer side effects.
Nigeria just approved $6.6 million to prevent HIV medication shortages and upgrade cancer treatment facilities across all six regions. The investment will keep life-saving drugs flowing to millions while building local manufacturing capacity.
Thousands of HIV patients who couldn't use simpler treatments now have a new one-pill-a-day option that works just as well as complex multi-drug regimens. The breakthrough brings relief to a "forgotten population" who've been taking multiple pills daily for decades.
Starting HIV treatment immediately after diagnosis can prevent irreversible brain damage, giving 1.75 million older South Africans living with the virus hope for healthier cognitive futures. New research shows that while HIV can reach the brain within two weeks of infection, prompt treatment stops damage before it starts.
Scientists discovered that when HIV develops resistance to the groundbreaking drug lenacapavir, the virus loses its ability to spread effectively. This finding offers hope that the twice-yearly injection can remain a powerful tool in preventing and treating HIV.
People living with HIV who struggle to take daily pills now have a breakthrough option: monthly injections that work twice as well at keeping the virus suppressed. A major study found this could transform care for thousands facing medication challenges.
The Democratic Republic of Congo just locked in $1.2 billion over five years to strengthen its healthcare system and fight diseases like HIV, malaria, and tuberculosis. The partnership with the United States will bring lifesaving treatments and training to millions while Congo invests $300 million of its own funds into the effort.
After decades of managing HIV with complex multi-pill regimens, older patients may soon have access to a single daily pill that works just as well. A groundbreaking clinical trial shows the new treatment suppressed the virus in 96% of participants while also improving cholesterol levels.
African researchers are transforming global HIV care through a groundbreaking four-country study that's helping millions stay healthy when standard treatments stop working. The Ndovu Study is creating lifesaving solutions for drug resistance that will reshape treatment guidelines worldwide.
Showing 20 of 23